ulcerative colitis

May 8, 2017May 8, 2017

InDex to Present Positive Results of Kappaproct for Ulcerative Colitis at Digestive Disease Week Meeting

News

InDex Pharmaceuticals today presents positive results of its lead drug candidate Kappaproct (cobitolimod) to treat moderate to severe active ulcerative colitis (UC) during the Digestive Disease Week congress now underway in Chicago. The Swedish company ... Read more

May 4, 2017

Protagonist to Present Preclinical Findings on PTG-200 for Crohn’s Disease at Conference

News

Protagonist Therapeutics will present preclinical research data on its investigational drug PTG-200 as a potential treatment for Crohn’s disease. The findings will be presented May 6 at the Digestive Disease Week conference ... Read more

May 2, 2017

Therapeutic Potential of Soybean Proteins for IBD Symptoms Seen in Mice

News

Results from a preclinical study at Penn State show that soybean proteins can reduce inflammation and protect the gut barrier in mouse models of inflammatory bowel disease (IBD). These results ... Read more

May 1, 2017May 2, 2017

The Differences Between the Bowel Conditions IBS and IBD

Columns, Finding the Silver Linings - a column by Lisa Burks

Inflammatory Bowel Disease is commonly misdiagnosed because the symptoms can point toward other conditions. This is why it can take a while to get the correct diagnosis. The most common misdiagnosis ... Read more

April 25, 2017April 25, 2017

Renflexis, Biosimilar for Remicade to Treat Crohn’s and UC, Approved by FDA

News

Renflexis (infliximab-abda), a biosimilar of Remicade (infliximab), has been approved in the U.S. to treat a number of autoimmune diseases, including adult and pediatric Crohn’s disease and adult ulcerative colitis. Samsung Bioepis, which ... Read more

April 11, 2017April 11, 2017

Yoga Improves Quality of Life for Ulcerative Colitis Patients, Clinical Trial Finds

News

Regular supervised 90-minute weekly yoga sessions over a 12-week period improved quality of life and reduced disease activity in people with ulcerative colitis (UC), compared to patients who got only self-care advice. ... Read more

April 10, 2017

Crohn’s Disease Patients Have an Increased Risk of Cancer

In this video from the Mayo Clinic, gastroenterologist Dr. John Kiesel discusses the findings of a study that looked at the increased risk of Crohn’s disease and ulcerative colitis patients developing ... Read more

April 6, 2017April 6, 2017

Finch, Takeda to Jointly Develop Microbiome Therapeutic for Ulcerative Colitis

News

Japan’s Takeda Pharmaceutical and Boston-based Finch Therapeutics will jointly develop the drug FIN-524 to treat ulcerative colitis, a form of inflammatory bowel disease (IBD). FIN-524 is Finch’s first microbiotic product candidate. The company says its live biotherapeutic product ... Read more

March 29, 2017March 29, 2017

Is It Ever Possible to Stop Thinking About Your IBD?

Columns, Crohn's Corner - a column by Judy Walters

I have a friend who is fairly new to the IBD world. She was diagnosed with ulcerative colitis last year. She’s had a hard course of it, with four hospitalizations, ... Read more